In pair of decisions, judges curtail using generics' sham-litigation claims against them later

The following article first appeared on Dec. 15 on MLex. For more information on MLex, including getting access to its exclusive content, please contact

Generic drugmakers cannot be found automatically...

Subscription required to view this article.

This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this content

If you do not currently subscribe to FTCWatch please contact us for subscription information:

FTCWatch is delivered in the following formats: via email alert and online at